Combination therapeutic effect of cisplatin along with Solanum trilobatum on benzo(a)pyrene induced experimental lung carcinogenesis

Natural Product Research

Volumn 22, Issue 12, 2008, Pages 1094-1106

  Venkatesan, P N ^a   Rajendran, P ^a   Ekambaram, G ^a   Sakthisekaran, D ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Benzo(a)pyrene; Cisplatin; Polyamines; Solanum trilobatum

Indexed keywords

5' NUCLEOTIDASE; BENZO[A]PYRENE; CISPLATIN; CORN OIL; GAMMA GLUTAMYLTRANSFERASE; HEXOSAMINE; HEXOSE; LACTATE DEHYDROGENASE; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; SIALIC ACID; SOLANUM TRILOBATUM EXTRACT; UNSPECIFIC MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ENZYME ACTIVITY; LUNG CANCER; LUNG CARCINOGENESIS; MALE; MONOTHERAPY; MOUSE; NONHUMAN; SOLANUM; SOLANUM TRILOBATUM;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZO(A)PYRENE; CISPLATIN; LUNG NEOPLASMS; MALE; MICE; PLANT EXTRACTS; SOLANUM;

ANIMALIA; MUS; SOLANUM TRILOBATUM; ZEA MAYS;

EID: 51649083594     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786410802267601     Document Type: Article

References (48)

1. Bandyopadhyay, M. and Ganguly, A. (1999) Serum and urine concentrations of diamine and polyamines in patients with uterine, ovarian, breast or rectal cancer. Journal of Medical Sciences Research, 27, pp. 645-647.
2. Bitter, T. and Muir, HM (1962) A modified uronic acid carbazole reaction. Analytical Biochemistry, 4, p. 330.
3. Chanda, R. and Ganguly, AK (1987) Diamine oxidase activity and tissue histamine content of human skin, breast and rectal carcinoma. Cancer Letters, 34, pp. 207-212.
4. Chen, L. and Liu, Y. (2000) Application of aryl hydrocarbon hydroxylase indiagnosis of lung cancer. Zhongua Jie He Xi Zhi., 23, pp. 151-154.
5. Cipolla, B., Guille, F. and Moulinoux, JP (1993) Polyamine and prostatic carcinoma: Clinical and therapeutic implications. European Urology, 24, pp. 124-131.
6. Conklin, KA (2000) Dietary antioxidants during cancer chemotherapy: Impact on chemotherapeutic effectiveness and development of side effects. Nutrition and Cancer, 37, pp. 1-18.
7. Cvitkovic, E., Spaulding, J., Bethune, V., Martin, J. and Whitmore, WF (1977) Improvement of cis-diammine dichloro platinum (NSC, 119875), therapeutic index in an animal model. Cancer, 39, pp. 1357-1361.
8. Dao, TL, Ip, C. and Pater, J. (1980) Serum alyl transferase and 5′-nucleotidase as reliable biomarkers in cancer. Journal of the National Cancer Institute, 65, pp. 529-534.
9. Davis, CW and Kuo, JF (1976) Ontogenetic changes in levels of phosphodiesterase for adenosine 3′:5′-monophosphate and glucosine 3′:5′-monophosphate in the lung, brain and heart from guinea pigs. Biochimica et Biophysica Acta, 444, pp. 554-562.
10. Dische, Z. and Shettles, LB (1948) A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination. Journal of Biological Chemistry, 175, pp. 595-600.
11. Duke, JA (1987) CRC handbook of medicinal herbs, CRC Press, Boca Raton, FL
12. Durak, I., Umitisik, CA, Canbolt, O., Akyol, O. and Kavutcu, M. (1993) Adenosine deaminase, 5′-nucleotidase, xanthine oxidase, SOD, CAT activities in cancerous and noncancerous human laryngeal tissues. Free Radical Biology and Medicine, 15, pp. 681-684.
13. Endo, YA (1978) Simple and sensitive method of analysis of histamine, putrescine and polyamines without the use of an amino acid analyser. Analytical Biochemistry, 89, pp. 235-246.
14. Ferrigno, D., Buccheri, G. and Biggi, A. (1994) Serum tumour markers in lung cancer history, biology and clinical applications. European Respiratory Journal, 7, pp. 186-197.
15. Fleischhacker, M., Beinert, T. and Possinger, K. (1999) Molecular genetic characteristics of lung cancer useful as 'real' tumor markers?. Lung Cancer, 25, pp. 7-24.
16. Govindan, S., Viswanathan, S., Vijayasekaran, V. and Alagappan, R. (2004) Further studies on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. Phytotherapy Research, 18, pp. 805-809.
17. Graziewicz, MA, Sayer, JM, Jerina, DM and Copeland, WC (2004) Nucleotide incorporation by human DNA polymerase γ opposite benzo[a]pyrene and benzo[c]phenanthrene diol epoxide adducts of deoxyguanosine and deoxyadenosine. Nucleic Acids Research, 32:1, pp. 397-405.
18. Handa, SS, Sharma, A. and Chakraborti, KK (1986) Natural products and plants as liver protecting drugs. Fitoterapia, 57, pp. 307-345.
19. Haugan, A. (2002) Women who smoke: Are women more susceptible to tobacco induced lung cancer?. Carcinogenesis, 23, pp. 227-229.
20. Hecht, SS, Updhyaya, P., Wang, M., Bliss, RL, Mcintee, EJ and Kenny, PM (2002) Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthio-carbamoyl)--cysteine and myo-inositol, individually and in combination. Carcinogenesis, 23:9, pp. 1455-1461.
21. Helmes, MH, Modia, A., Moneim, EL, Moustafae, MS, Bale, EL and Safinoz, MEL (1998) Clinical values of serum LDH, ceruloplasmin and lipid bound sialic acid in monitoring patients with malignant lymphomas. Journal of Medical Sciences Research, 26, pp. 613-617.
22. Herzfeld, A. and Greengard, O. (1997) The effect of lymphoma and other neoplasms on hepatic and plasma enzymes of the host rat. Cancer Research, 37, pp. 231-238.
23. Hucks, RM (1983) Pathological and biochemical aspects of tumor promotion. Carcinogenesis, 4, pp. 1209-1214.
24. Kalant, H. and Roschlau, WHE (1998) Principles of medical pharmacology, Oxford University Press, New York
25. King, J. (1965) The dehydrogenase or oxidoreductases-Lactate dehydrogenase. Practical clinical enzymology, pp. 83-93. Nostrand, London
26. Komlosh, A., Volohonsky, G., Porat, N., Taby, C., Oesch, F. and Stork, AA (2002) γ-Glutamyl transpeptidase and glutathione biosynthesis in nontumorigenic and tumorigenic rat liver oral cell lines. Carcinogenesis, 23, pp. 671-676.
27. Luly, P., Barnabei, O. and Tria, E. (1972) Hormonal control of in vitro plasma membrane bound Na+/K+ ATPase of rat liver. Biochimica et Biophysica Acta, 282, pp. 447-452.
28. Maher, JF (1976) Toxic nephrology. The kidney, 2, pp. 1355-1384. W.B. Saunders, Philadelphia
29. Mildred, K., Richerd, L., Joseph, G., Alexander, W. and Conney, A. (1981) Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally accruing flavonoids. Cancer Research, 41, pp. 67-72.
30. Mohanan, PV and Devi, KS (1977) Effect of Sobatum on tumour development and chemically induced carcinogenesis. Cancer Letters, 112, pp. 219-223.
31. Nadkarni, KM (1976) Indian materia medica, 1, pp. 1153-1154. Popular Prakasan Pvt. Ltd, Bombay
32. Niebes, P. (1972) Determination of enzyme and degradation products of GAG metabolism in the serum of healthy and varicose subjects. Clinica Chimica Acta, 42, pp. 399-408.
33. Nilssen, O., Forde, OH and Brenn, T. (1990) The tromso study: Distribution and population determinants of gamma-glutamyl transferase. American Journal of Epidemiology, 132:2, pp. 318-326.
34. Orlowski, M. and Meister, A. (1965) Isolation of γ-glutamyl transpeptidase from hog kidney. Journal of Biological Chemistry, 240, pp. 338-347.
35. Rosenberg, B., Vancam, PL, Trosko, JE and Mansour, VH (1969) Platinum compounds a new class of potent antitumor agents. Nature, 22, pp. 385-386.
36. Rozenzweigh, M., VanHoff, DD, Slavik, M. and Muggia, FM (1977) Cis-diamminedichloro platinum (II), A new anticancer drug. Annals of International Medicine, 86, pp. 803-812.
37. Schilsky, RL (1980) Renal and metabolic toxicities of cancer chemotherapy. Seminars in Oncology, 9, pp. 75-83.
38. Shahjahan, M., Sabitha, KE, Jainu, M. and ShyamalaDevi, CS (2004) Effect of Solanum trilobatum against carbon tetrachloride induced hepatic damagein albino rats. Indian Journal of Medical Research, 120, pp. 194-198.
39. Subramani, J., Josekutty, PC, Metha, AR and Bhatt, PN (1989) Solasodine levels in Solanum sisymbriifolium Lam. Indian Journal of Experimental Biology, 27, pp. 189-194.
40. Takami, H. and Nishoka, K. (1980) The effect of glycosylation inhibitors on receptor mediated phagocytosis and carbohydrate incorporation by mouse peritoneal macrophages. Federation Proceedings, 37, pp. 1685-1691.
41. Thirunavukkarasu, C. and Sakthisekaran, D. (2003) Influence of sodium selenite on glycoprotein contents in normal and N-nitrosodiethylamine initiated and phenobarbital promoted rat liver tumors. Pharmacological Research, 48, pp. 167-173.
42. Thomas, T. and Thomas, TJ (2001) Polyamines in cell growth and cell death, molecular mechanisms and therapeutic applications. Cellular and Molecular Life Sciences, 58, pp. 244-258.
43. Thompson, LF, Ruedi, JM, O'Connon, RD and Bastian, JF (1986) Ecto5′-nucleotidase expression during human B cell development. An explanation for the heterogenicite in B-lymphocyte aceto 5′-nucleotidase activity in patients with hypogammaglobulinemia. The Journal of Immunology, 137, pp. 2459-2500.
44. Ueoka, H., Tabata, M., Kiura, K., Shibayama, T., Gemba, K. Segwa, Y. et al. (1999) Fractionated administration of irnotecan and cisplatin for treatment of lung cancer a phase I study. British Journal of Cancer, 79, pp. 5-6.
45. Vanisree, AJ and Shyamaladevi, CS (1998) Effect of therapeutic strategy established by N-acetyl cysteine and vitamin C on the activities of tumour marker enzymes in vitro. Indian Journal of Pharmacology, 31, pp. 275-278.
46. Wagner, WD (1974) More sensitive assay discriminating galactosamine and glucosamine in mixtures. Analytical Biochemistry, 94, pp. 394-397.
47. Warren, L. (1954) The thiobarbituric acid assay of sialic acid. Journal of Biological Chemistry, 234, pp. 1971-1975.
48. Williams, CJ and Whitehouse, JMA (1979) Cisplatinum: A new anticancer agent. British Medical Journal, 1, pp. 1689-1692.